<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Yanamandra U</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>India is the epicenter of diabetes mellitus (DM). The relationship between COVID and DM in age/gender-matched non-diabetics has not been studied yet. The role of DM in predicting the disease severity and outcome in COVID patients might provide new insight for effective management.&lt;h4>Methods&lt;/h4>We conducted a prospective comparative study at a COVID care center from 25th April-31st May 2021. Among 357 severe-COVID patients screened, all consecutive diabetes (n-113) and age/gender-matched non-diabetes (n-113) patients were recruited. All diabetics and non-diabetics at admission were subjected to high resolution computed tomography (HRCT) chest and inflammatory markers (C-reactive protein (CRP), D-dimer, ferritin, interleukin-6 (IL-6), lactate dehydrogenase (LDH), Neutrop</pubmed_abstract><journal>Medical journal, Armed Forces India</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9393750</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Sweetness and positivity together aren't a happy ending: Case controlled study amongst severe COVID-19 for impact of diabetes mellitus on survival.</pubmed_title><pmcid>PMC9393750</pmcid><pubmed_authors>Rajagopal S</pubmed_authors><pubmed_authors>Aggarwal B</pubmed_authors><pubmed_authors>Yanamandra U</pubmed_authors><pubmed_authors>Sahu R</pubmed_authors><pubmed_authors>Aggarwal N</pubmed_authors><pubmed_authors>Sai Kumar PB</pubmed_authors><pubmed_authors>Kaur P</pubmed_authors><pubmed_authors>Singh A</pubmed_authors><pubmed_authors>Duhan G</pubmed_authors><pubmed_authors>Menon AS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sweetness and positivity together aren't a happy ending: Case controlled study amongst severe COVID-19 for impact of diabetes mellitus on survival.</name><description>&lt;h4>Background&lt;/h4>India is the epicenter of diabetes mellitus (DM). The relationship between COVID and DM in age/gender-matched non-diabetics has not been studied yet. The role of DM in predicting the disease severity and outcome in COVID patients might provide new insight for effective management.&lt;h4>Methods&lt;/h4>We conducted a prospective comparative study at a COVID care center from 25th April-31st May 2021. Among 357 severe-COVID patients screened, all consecutive diabetes (n-113) and age/gender-matched non-diabetes (n-113) patients were recruited. All diabetics and non-diabetics at admission were subjected to high resolution computed tomography (HRCT) chest and inflammatory markers (C-reactive protein (CRP), D-dimer, ferritin, interleukin-6 (IL-6), lactate dehydrogenase (LDH), Neutrop</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2026-03-17T16:07:43.458Z</modification><creation>2024-10-17T15:38:21.132Z</creation></dates><accession>S-EPMC9393750</accession><cross_references><pubmed>36034073</pubmed><doi>10.1016/j.mjafi.2022.06.010</doi></cross_references></HashMap>